A new survey has found that patterns of substance use are changing among the younger generation, with the use of hallucinogens and cannabis rising while alcohol is becoming increasingly unpopular. The survey was designed to offer insight into the trends of national drug use among young adults annually and began gathering data in the mid-1970s.
These findings were reported in “Monitoring the Future,” a publication by the Institute for Social Research at the University of Michigan. The results show that the use of cannabis last year continued to rise, as observed in previous years, with the use of hallucinogens such as LSD also increasing.
Physicians state that the survey’s results reflect their experiences treating young adults and teens for substance use. For example, Dr. Maria Rahmandar of the Lurie Children’s Hospital of Chicago stated that the survey’s findings were consistent with what she had observed clinically, adding that she’d noticed an increase in patients’ reports of psychedelic substances.
Hallucinogens and psychedelics suchas psilocybin mushrooms, MDMA and LSD have become more popular as new studies find that the substances could be utilized in the treatment of mental health conditions like depression and post-traumatic stress disorder. Rahmandar, who is the medical director of the hospital’s substance-use program, explained that most individuals assumed that the substances were beneficial, given the ongoing studies. However, she noted that unlike cannabis, which has been decriminalized in various states across the country, psychedelic substances were still illegal to use, with the exception of research studies.
The study also found that cannabis was considered to be the least dangerous of all illicit drugs. The perception of risk has been declining since the year 2006, when roughly 55% of the respondents considered the regular use of cannabis as dangerous. This is in comparison to the 21% of respondents who still considered it dangerous last year.
Rahamandar adds that the THC concentration in products these days is so much higher in contrast to the marijuana used in the ’60s. THC or tetrahydrocannabinol is the psychoactive component found in marijuana that induces a high. In addition, Rahmandar explained, doctors had observed a link between an increased risk of psychosis and higher potency products.
The CDC warns that young people who regularly indulge in cannabis have higher chances of developing schizophrenia, which is a chronic mental health condition that is characterized by hallucinations and delusional thoughts.
Public health experts also note that binge drinking is decreasing while vaping has levelled out. Many of those opting to consume marijuana are doing so for therapeutic purposes, and the dose-measuring devices made by RYAH Group Inc. (CSE: RYAH) could come in handy for such people to ensure that they are taking the right doses to give them the results they want.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]
CNW420 is part of the InvestorBrandNetwork.